Business news with perspective

The grill maker's 1-for-50 reverse stock split aims to avoid delisting, but deep financial woes and historical data suggest a tough road ahead.

ROHM's new SiC modules are now on DigiKey, democratizing access to next-gen power tech for EVs and industry, challenging market leaders.

With two key executive appointments, BST Global signals a strategic acceleration of its AI-powered project intelligence mission for the AEC industry.

The midstream firm is refinancing debt and buying back preferred units, aiming for a simpler, more flexible financial future. What does this mean for NGL?

Laird Superfood acquires Navitas for $38.5M, fueled by a $50M Nexus Capital investment, creating a new powerhouse in the functional nutrition market.

A new platform merges AI, behavioral science, and global strategy, aiming to transform employee wellbeing from a perk into a core performance driver.

The nation's largest landscaper affirms its financial health by paying an $8.8M cash dividend, avoiding share dilution and signaling confidence to investors.

Crane NXT adds Benchmark Electronics CEO Jeffrey Benck to its board, signaling a strategic pivot towards deeper tech expertise as a veteran director departs.

The organic kids' food brand reports impressive sales and a strong IPO, but investors are keenly watching its strategy for long-term profitability.

Shimmick reports a second straight quarter of positive EBITDA, signaling its strategic shift to core infrastructure is paying off despite a net loss.

Universal Electronics is restructuring for profitability amid falling sales, raising questions about the future of the connected home market.

Lucara Diamond Corp. finalizes a massive financing package for its Karowe mine expansion, averting a crisis but taking on costly debt to secure its future.

A cult-favorite St. Louis creamery, fueled by a $6M investment from a franchise titan, is set to go national with an innovative model for franchisees.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

Colgate-Palmolive signals confidence with its 63rd annual dividend hike and appoints Bristol Myers Squibb's CEO to its board, a strategic health pivot.

After a tough 2025, the gaming giant touts record margins and an aggressive 2026 plan, betting on new gear and a massive market catalyst for growth.

PitchBook integrates its private market data into Perplexity's AI, promising a new era of fast, verifiable, and conversational financial intelligence.

Maker's Pride is closing two Midwest facilities as part of a strategic shift to automation, leaving communities in Utah and Minnesota facing an uncertain future.